{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T18:28:39Z","timestamp":1784312919598,"version":"3.55.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Department of Science and technology (DST), India"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.neuroscience.2012.11.006","type":"journal-article","created":{"date-parts":[[2012,11,14]],"date-time":"2012-11-14T22:01:01Z","timestamp":1352930461000},"page":"420-431","source":"Crossref","is-referenced-by-count":57,"special_numbering":"C","title":["Anti-inflammatory properties rather than anti-oxidant capability is the major mechanism of neuroprotection by sodium salicylate in a chronic rotenone model of Parkinson\u2019s disease"],"prefix":"10.1016","volume":"231","author":[{"given":"P.","family":"Thakur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Nehru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2012.11.006_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(02)01828-9","article-title":"Anti-inflammatory effects of aspirin and sodium salicylate","volume":"447","author":"Amann","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2012.11.006_b0010","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1038\/nrn1434","article-title":"Oxidative stress in neurodegeneration, cause or consequence","volume":"5","author":"Anderson","year":"2004","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.neuroscience.2012.11.006_b0015","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1046\/j.1471-4159.1998.71041635.x","article-title":"Aspirin and salicylate protect against MPTP-induced dopamine depletion in mice","volume":"71","author":"Aubin","year":"1998","journal-title":"J. Neurochem"},{"key":"10.1016\/j.neuroscience.2012.11.006_b0020","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/sj.bjp.0702441","article-title":"4-Trifluoromethyl derivatives of salicylate, triflusal and its main metabolite 2-hydroxy-4-trifluoromethylbenzoic acid, are potent inhibitors of nuclear factor kappaB activation","volume":"126","author":"Bayon","year":"1999","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.neuroscience.2012.11.006_b0025","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1152\/jappl.1999.87.1.74","article-title":"Free radical activity, antioxidant enzyme, and glutathione changes with muscle stretch injury in rabbits","volume":"87","author":"Best","year":"1999","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.neuroscience.2012.11.006_b0030","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejphar.2006.09.010","article-title":"Involvement of adenosinergic receptor system in an animal model of tardive dyskinesia and associated behavioural, biochemical and neurochemical changes","volume":"552","author":"Bishnoi","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2012.11.006_b0035","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/0003-2697(80)90404-2","article-title":"Optimization of conditions for the colorimetric determination of citrulline, using diacetyl monoxime","volume":"107","author":"Boyde","year":"1980","journal-title":"Anal Biochem J"},{"issue":"3","key":"10.1016\/j.neuroscience.2012.11.006_b0040","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1602\/neurorx.2.3.484","article-title":"Toxin-induced models of Parkinson\u2019s disease","volume":"2","author":"Bov\u00e9","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.neuroscience.2012.11.006_b0045","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/9780470942390.mo110165","article-title":"Assessment of motor coordination and balance in mice using the rotarod, elevated bridge, and footprint tests","volume":"2","author":"Brooks","year":"2012","journal-title":"Curr Protoc Mouse Biol"},{"issue":"1","key":"10.1016\/j.neuroscience.2012.11.006_b0050","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.vascn.2006.02.015","article-title":"Modified protein carbonyl assay detects oxidised membrane proteins, a new tool for assessing drug- and chemically-induced oxidative cell injury","volume":"56","author":"Burcham","year":"2007","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1016\/j.neuroscience.2012.11.006_b0055","first-page":"401","article-title":"The role of neuroinflammation in Parkinson\u2019s disease","volume":"vol. 18","author":"Chen","year":"2011"},{"key":"10.1016\/j.neuroscience.2012.11.006_b0060","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF00421964","article-title":"On catalepsy and catatonia and the predictability of the catalepsy test for neuroleptic activity","volume":"34","author":"Costall","year":"1974","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.neuroscience.2012.11.006_b0065","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1254\/jjp.32.335","article-title":"Inhibition of monoamine oxidase by 3\u2032-methyl-4-dimethylamino azobenzene (3\u2032-me-DAB) in rat liver mitochondria","volume":"32","author":"Egashira","year":"1982","journal-title":"Jpn J Pharmacol"},{"issue":"2","key":"10.1016\/j.neuroscience.2012.11.006_b0070","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.expneurol.2007.02.008","article-title":"Non-steroidal anti-inflammatory drugs in Parkinson\u2019s disease","volume":"205","author":"Esposito","year":"2007","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2012.11.006_b0075","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s002109900079","article-title":"Salicylate protects against MPTP-induced impairments in dopaminergic neurotransmission at the striatal and nigral level in mice","volume":"360","author":"Ferger","year":"1999","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.neuroscience.2012.11.006_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-5728(01)00342-3","article-title":"Increased post-traumatic survival of neurons in IL-6-knockout mice on a background of EAE susceptibility","volume":"119","author":"Fisher","year":"2001","journal-title":"J Neuroimmunol"},{"issue":"3","key":"10.1016\/j.neuroscience.2012.11.006_b0085","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1046\/j.1525-1373.1999.d01-140.x","article-title":"Antioxidants, oxidative stress and degenerative neurological disorders","volume":"222","author":"Floyd","year":"1999","journal-title":"Proc Soc Exp Biol Med"},{"issue":"15","key":"10.1016\/j.neuroscience.2012.11.006_b0090","doi-asserted-by":"crossref","first-page":"6181","DOI":"10.1523\/JNEUROSCI.23-15-06181.2003","article-title":"Critical role for microglial NADPH oxidase in rotenone-induced degeneration of dopaminergic neurons","volume":"23","author":"Gao","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2012.11.006_b0095","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S0022-3565(24)29207-7","article-title":"Sodium salicylate inhibits prostaglandin formation without affecting the induction of cyclooxygenase-2 by bacterial lipopolysaccharide in vivo","volume":"299","author":"Giuliano","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2012.11.006_b0100","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1038\/sj.bjp.0702518","article-title":"Ex vivo assay to determine the cyclooxygenase selectivity of non-steroidal anti-inflammatory drugs","volume":"26","author":"Giuliano","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuroscience.2012.11.006_b0105","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1126\/science.274.5291.1383","article-title":"Neuroprotection by aspirin and sodium salicylate through blockade of NF-\u03baB activation","volume":"274","author":"Grilli","year":"1996","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.neuroscience.2012.11.006_b0110","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.expneurol.2005.01.013","article-title":"Oxidative stress and inflammation in Parkinson\u2019s disease: is there a causal link?","volume":"193","author":"Hald","year":"2005","journal-title":"Exp Neurol"},{"issue":"3","key":"10.1016\/j.neuroscience.2012.11.006_b0115","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/(SICI)1097-4547(19990801)57:3<388::AID-JNR11>3.0.CO;2-2","article-title":"Interleukin-1\u03b2, inducible nitric oxide synthase, and nuclear factor-\u03baB are induced in morphologically distinct microglia after rat hippocampal lipopolysaccharide\/interferon-\u03b3 injection","volume":"57","author":"Hartlage-R\u00fcbsamen","year":"1999","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neuroscience.2012.11.006_b0120","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1046\/j.1471-4159.1995.64020919.x","article-title":"Enzymatic oxidation of dopamine: the role of prostaglandin H synthase","volume":"64","author":"Hastings","year":"1995","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2012.11.006_b0125","first-page":"567","article-title":"Hydroxyl radicals generation and post ischemic reperfusion brain damage implications for neuroprotection","volume":"48","author":"Kanazawa","year":"1996","journal-title":"No to Shinkei. Brain Nerve"},{"key":"10.1016\/j.neuroscience.2012.11.006_b0130","doi-asserted-by":"crossref","first-page":"6309","DOI":"10.1523\/JNEUROSCI.20-16-06309.2000","article-title":"Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain, role of microglia","volume":"20","author":"Kim","year":"2000","journal-title":"J Neurosci"},{"issue":"10\u201311","key":"10.1016\/j.neuroscience.2012.11.006_b0135","first-page":"1343","article-title":"Regulation of the expression of inducible nitric oxide synthase","volume":"384","author":"Kleinert","year":"2003","journal-title":"Biol Chem"},{"key":"10.1016\/j.neuroscience.2012.11.006_b0140","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0003-9861(78)90479-4","article-title":"Generation of superoxide radical during auto-oxidation of hydroxylamine and an assay of superoxide dismutase","volume":"186","author":"Kono","year":"1978","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.neuroscience.2012.11.006_b0145","series-title":"Handbook of experimental pharmacology","author":"Kulkarni","year":"1999"},{"key":"10.1016\/j.neuroscience.2012.11.006_b0150","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1124\/mol.58.6.1247","article-title":"Methamphetamine-induced neurotoxicity is attenuated in transgenic mice with a null mutation for interleukin-6","volume":"58","author":"Ladenheim","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.neuroscience.2012.11.006_b0155","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s11481-009-9176-0","article-title":"Neuroinflammation in Parkinson\u2019s disease","volume":"4","author":"Lee","year":"2009","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1016\/j.neuroscience.2012.11.006_b0160","first-page":"713517","article-title":"Inflammatory mechanisms of neurodegeneration in toxin-based models of Parkinson\u2019s disease","volume":"2011","author":"Litteljohn","year":"2010","journal-title":"Parkinsons Dis."},{"key":"10.1016\/j.neuroscience.2012.11.006_b0165","series-title":"Methods in enzymatic analysis","first-page":"885","author":"Luck","year":"1971"},{"issue":"4","key":"10.1016\/j.neuroscience.2012.11.006_b0170","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1017\/S0317167100032212","article-title":"3-Nitropropionic acid-exogenous animal neurotoxin and possible human striatal toxin","volume":"18","author":"Ludolph","year":"1991","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.neuroscience.2012.11.006_b0175","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000068322","article-title":"Role and mechanisms of interleukin-1 in the modulation of neurotoxicity","volume":"10","author":"Ma","year":"2002","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.neuroscience.2012.11.006_b0180","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1750-1326-4-24","article-title":"Oxidative modifications, mitochondrial dysfunction, and impaired protein degradation in Parkinson\u2019s disease, how neurons are lost in the Bermuda triangle","volume":"4","author":"Malkus","year":"2009","journal-title":"Mol Neurodegener"},{"issue":"10","key":"10.1016\/j.neuroscience.2012.11.006_b0185","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/mds.21010","article-title":"Behavioral models of Parkinson\u2019s disease in rodents: a new look at an old problem","volume":"21","author":"Meredith","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuroscience.2012.11.006_b0190","doi-asserted-by":"crossref","first-page":"11693","DOI":"10.1073\/pnas.90.24.11693","article-title":"Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase","volume":"90","author":"Mitchell","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.neuroscience.2012.11.006_b0195","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0006-8993(00)02189-2","article-title":"Neuroprotection by sodium salicylate against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity","volume":"864","author":"Mohanakumar","year":"2000","journal-title":"Brain Res"},{"issue":"6","key":"10.1016\/j.neuroscience.2012.11.006_b0200","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.3390\/ph3061812","article-title":"Non-Steroidal Anti-Inflammatory Drugs in Alzheimer\u2019s disease and Parkinson\u2019s disease, reconsidering the role of neuroinflammation","volume":"3","author":"Moore","year":"2010","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.neuroscience.2012.11.006_b0205","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.neuro.28.061604.135718","article-title":"Molecular pathophysiology of Parkinson\u2019s disease","volume":"28","author":"Moore","year":"2005","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.neuroscience.2012.11.006_b0210","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.brainres.2008.01.074","article-title":"Behavioral alterations in rotenone model of Parkinson\u2019s disease: attenuation by co-treatment of centrophenoxine","volume":"12011","author":"Nehru","year":"2008","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2012.11.006_b0215","first-page":"623","article-title":"Differential inhibition of human prostaglandin endoperoxide synthase-1 and -2 by nonsteroidal anti-inflammatory drugs","volume":"48","author":"Patrignani","year":"1997","journal-title":"J Physiol Pharmacol"},{"issue":"1\u20132","key":"10.1016\/j.neuroscience.2012.11.006_b0220","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jneuroim.2010.02.018","article-title":"Nigral neurodegeneration triggered by striatal AdIL-1 administration can be exacerbated by systemic IL-1 expression","volume":"222","author":"Pott-Godoy","year":"2010","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neuroscience.2012.11.006_b0225","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00702-010-0428-1","article-title":"Neuroinflammation is a key player in Parkinson\u2019s disease and a prime target for therapy","volume":"117","author":"Qian","year":"2010","journal-title":"J Neural Transm"},{"key":"10.1016\/j.neuroscience.2012.11.006_b0230","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1006\/cimm.1994.1041","article-title":"Role of calcium in the activation of mouse peritoneal macrophages: induction of NO synthase by calcium ionophores and thapsigargin","volume":"53","author":"Raddassi","year":"1994","journal-title":"Cell Immunol"},{"key":"10.1016\/j.neuroscience.2012.11.006_b0235","series-title":"Neuroinflammation: mechanisms and management","first-page":"391","article-title":"Inflammatory mechanism in Parkinson\u2019s disease","author":"Rogers","year":"2003"},{"key":"10.1016\/j.neuroscience.2012.11.006_b0240","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0006-8993(02)04174-4","article-title":"Nonsteroidal anti-inflammatory drug sodium salicylate, but not diclofenac or celecoxib, protects against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats","volume":"966","author":"Sairam","year":"2003","journal-title":"Brain Res"},{"issue":"5","key":"10.1016\/j.neuroscience.2012.11.006_b0245","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1037\/0735-7044.102.5.748","article-title":"The catalepsy test: its ups and downs","volume":"102","author":"Sanberg","year":"1988","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.neuroscience.2012.11.006_b0250","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0304-3940(03)00172-1","article-title":"Selective microglial activation in the rat rotenone model of Parkinson\u2019s disease","volume":"341","author":"Sherer","year":"2003","journal-title":"Neurosci Lett"},{"issue":"5","key":"10.1016\/j.neuroscience.2012.11.006_b0255","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1161\/01.HYP.35.5.1085","article-title":"Effects of aspirin-like drugs on nitric oxide synthesis in rat vascular smooth muscle cells","volume":"35","author":"Shimpo","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.neuroscience.2012.11.006_b0260","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/01.WCB.0000126563.85360.75","article-title":"Changes of dopamine turnover in the progression of Parkinson\u2019s disease as measured by positron emission tomography: their relation to disease-compensatory mechanisms","volume":"24","author":"Sossi","year":"2004","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.neuroscience.2012.11.006_b0265","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1096\/fj.01-0390rev","article-title":"Cyclooxygenase-independent actions of cyclooxygenase inhibitors","volume":"15","author":"Tegeder","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.neuroscience.2012.11.006_b0270","series-title":"Neuropsychopharmacology: the fifth generation of progress","first-page":"1761","article-title":"Neurocircuitry of Parkinson\u2019s disease","author":"Wichmann","year":"2002"},{"key":"10.1016\/j.neuroscience.2012.11.006_b0275","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1042\/bj0990667","article-title":"Mechanism of lipid peroxide formation in animal tissue","volume":"99","author":"Wills","year":"1966","journal-title":"Biochem J"},{"issue":"5","key":"10.1016\/j.neuroscience.2012.11.006_b0280","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.mito.2010.05.014","article-title":"Mitochondrial dysfunction, a potential link between neuroinflammation and neurodegeneration?","volume":"10","author":"Witte","year":"2010","journal-title":"Mitochondrion"},{"issue":"6","key":"10.1016\/j.neuroscience.2012.11.006_b0285","doi-asserted-by":"crossref","first-page":"e20677","DOI":"10.1371\/journal.pone.0020677","article-title":"Edaravone guards dopamine neurons in a rotenone model for Parkinson\u2019s disease","volume":"6","author":"Xiong","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuroscience.2012.11.006_b0290","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.bbadis.2008.09.009","article-title":"Targets for neuroprotection in Parkinson\u2019s disease","volume":"1792","author":"Yacoubian","year":"2009","journal-title":"Biochim Biophys Acta"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452212011001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452212011001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T22:07:55Z","timestamp":1745186875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452212011001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":58,"alternative-id":["S0306452212011001"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2012.11.006","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}